Global Eye Drops (Artificial Tear) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Eye Drops (Artificial Tear) market size was valued at US$ 3497 million in 2024 and is forecast to a readjusted size of USD 4471 million by 2031 with a CAGR of 3.6% during review period.

Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.

The artificial tears and lubricants market is driven by the increasing prevalence of dry eye syndrome and the growing awareness of the importance of ocular health. Artificial tears and lubricants are eye drops and ointments used to alleviate dryness and discomfort in the eyes caused by various factors, including aging, digital device use, and environmental conditions. The rise in the aging population and the prevalence of conditions like Sjögren"s syndrome contribute to market growth as artificial tears provide relief and improve ocular surface health. Moreover, advancements in formulation technology and the development of preservative-free and longer-lasting products have enhanced their efficacy and patient compliance. However, the market also faces challenges, including the need for proper diagnosis and patient education to ensure appropriate product selection and usage. Additionally, addressing competition from alternative dry eye treatments and maintaining affordable pricing can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective artificial tears and lubricants, collaborate with eye care professionals to promote their benefits, and address the challenges to meet the increasing demand for ocular health solutions.

This report is a detailed and comprehensive analysis for global Eye Drops (Artificial Tear) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Eye Drops (Artificial Tear) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Eye Drops (Artificial Tear) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Eye Drops (Artificial Tear) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Eye Drops (Artificial Tear) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Eye Drops (Artificial Tear)

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Eye Drops (Artificial Tear) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Eye Drops (Artificial Tear) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Allergy Eye Care

Standard Eye Care

Market segment by Application

Pharmacy

Internet

Grocery

Optical Chains

Major players covered

Allergan

Alcon

Novartis

Santen Pharma

Johnson & Johnson

Bausch & Lomb

Thea pharmaceuticals

URSAPHARM

SIMILASAN

Akorn

United Laboratories

Sun Pharmaceutical

Jianfeng Group

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Eye Drops (Artificial Tear) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Eye Drops (Artificial Tear), with price, sales quantity, revenue, and global market share of Eye Drops (Artificial Tear) from 2020 to 2025.

Chapter 3, the Eye Drops (Artificial Tear) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Eye Drops (Artificial Tear) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Eye Drops (Artificial Tear) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Eye Drops (Artificial Tear).

Chapter 14 and 15, to describe Eye Drops (Artificial Tear) sales channel, distributors, customers, research findings and conclusion.